Acquired interferon γ responsiveness during Caco-2 cell differentiation: Effects on iNOS gene expression

Gut

Volumn 44, Issue 5, 1999, Pages 659-665

  Chavez, A M ^a   Morin, M J ^a   Unno, N ^a   Fink, M P ^a   Hodin, R A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Inflammation; Interferon receptor; Intestinal epithelium; Nitric oxide synthase

Indexed keywords

CYCLOHEXIMIDE; DEXAMETHASONE; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PYRROLIDINE DITHIOCARBAMATE; RECOMBINANT GAMMA INTERFERON;

ARTICLE; CELL DIFFERENTIATION; ENTERITIS; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY;

EID: 0032966372     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.5.659     Document Type: Article

References (40)

1. 1 Traber PG. Differentiation of intestinal epithelial cells: lessons from the study on intestine specific gene expression. J Lab Clin Med 1994;123:467-77.
2. 2 Deitch EA. The role of intestinal barrier failure anc bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125 403-4.
3. 3 Ziegler TR, Smith RJ, O'Dwyer ST, et al. Increased intestinal permeability associated with infection in burn patients Arch Surg 1988;123:1313-19.
4. 4 Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-35.
5. 5 Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliorates lipopolysaccharide-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997;113:1246-57.
6. 6 Mullin JM, Snock KV. Effect of tumor necrosis factor or epithelial tight junctions and transepithelial permeability Cancer Res 1990;50:2172-6.
7. 7 Adams RB, Planchon SM, Roche JK. IFN-γ modulation of epithelial barrier function: time course, reversibility, and site of cytokine binding. J Immunol 1993;150:2356-63.
8. 8 Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-7.
9. 9 Unno N, Menconi MJ, Smith M, et al. Nitric oxide mediates interferon-γ-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 1995;23: 1170-6.
10. 10 Salzman AL, Menconi MJ, Unno N, et al. Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 1995;268:G361-73.
11. 11 Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-31.
12. 12 Salzman AL. Nitric oxide in the gut. New Horizons 1995;3: 352-64.
13. 13 Chen K, Inoue M, Okada A. Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury. Biochem Biophys Res Commun 1996;224:703-8.
14. 14 Morin MJ, Unno N, Hodin RA, et al. Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 1998;26:1258-64.
15. 15 Chavez AM, Morin MJ, Unno N, et al. Cellular responsiveness to interferon-gamma is acquired during enterocyte differentiation in vitro: effects on inducible nitric oxide synthase gene expression. Surgical Forum 1997;48:219-21
16. 15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
17. 17 Chirgwin JM, Przybla AE, MacDonald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1980;18:5294-9.
18. 18 Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragment to high specific activity. Anal Biochem 1983;132:6-13.
19. 19 Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90: 3491-5.
20. 20 Traber PG, Yu L, Wu GD, et al. Sucrase-isomaltase gene expression along crypt-villus axis of human small intestine is regulated at level of mRNA abundance. Am J Physiol 1992;262:G123-30.
21. 21 Cleveland DW, Lopata MA, MacDonald RJ, et al. Number and evolutionary conservation of alpha-and beta-tubulin and cytoplasmic beta-and gamma-actin genes using specified cloned cDNA probes. Cell 1980;20:95-105.
22. 22 Schreck R, Meier B, Mannel DN, et al. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992;175:1181-94.
23. 23 Xie Q, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
24. 24 Zweibaum A, Laburthe M, Grasset E, et al. Use of cultured cell lines in studies of intestinal cell differentiation and function. In: Rauner BB, ed. Handbook of physiology-Section 6: The gastrointestinal system. Vol IV. Bethesda: American Physiological Society, 1991:223-55.
25. 25 Deem RL, Shanahan F, Targan SR. Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol 1991;83:79-84.
26. 26 McGowan I, Radford-Smith G, Jewell DP. Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 1994; 8:1569-75.
27. 27 Simpson SJ, Hollander GA, Mizoguchi E, et al. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis. Eur J Immunol 1997;27:17-25.
28. 28 Colgan SP, Resnick MB, Parkos CA, et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994;153:2122-9.
29. 29 Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996;270: G225-37.
30. 30 Hoffman RA, Zhang G, Nussler NC, et al. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 1997;272:G383-92.
31. 31 Tepperman BL, Brown JF, Korolkiewicz R, et al. Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge. J Pharmacol Exp Ther 1984;271:1477-82.
32. 32 Tepperman BL, Brown JF, Whittle BJR. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993;265:G214-18.
33. 33 Sorrells DL, Friend C, Koltuksuz U, et al. Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg 1996;131:1155-63.
34. 34 Lau LF, Nathans D. Expression of a set of growth-related immediate early genes in BALB/c3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 1987;84:1182-6.
35. 35 Melillo G, Cox GW, Biragyn A, et al. Regulation of nitric-oxide synthase mRNA expression by interferon-γ and picolinic acid. J Biol Chem 1994;269:8128-33.
36. 36 Salzman AL, Denenberg AG, Ueta I, et al. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 1996;270:G565-73.
37. 37 Auphan NJ, DiDonato A, Rosette C, et al. Immunosuppression by glucocorticoid: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995;270:286-90.
38. 38 Vecchini F, Pringault E, Billar TR, et al. Decreased activity of inducible nitric oxide synthase type 2 and modulation of the expression of glutathione S-transferase a, bcl-2, and metallothioneins during the differentiation of CaCo-2 cells. Cell Growth Differ 1997;8:261-8.
39. 39 Jenkins DC, Charles IG, Baylis SA, et al. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 1994;70:847-9.
40. 40 Kolios G, Brown Z, Robson RL, et al. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol 1995;116:2866-72.